NCT00440388 2010-08-27Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's LymphomaAscenta TherapeuticsPhase 2 Completed23 enrolled